Ernest H S Choy
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Aletaha D, Kerschbaumer A, Kastrati K, Dejaco C, Dougados M, McInnes I, Sattar N, Stamm T, Takeuchi T, Trauner M, van der Heijde D, Voshaar M, Winthrop K, Ravelli A, Betteridge N, Burmester G, Bijlsma J, Bykerk V, Caporali R, Choy E, Codreanu C, Combe B, Crow M, de Wit M, Emery P, Fleischmann R, Gabay C, Hetland M, Hyrich K, Iagnocco A, Isaacs J, Kremer J, Mariette X, Merkel P, Mysler E, Nash P, Nurmohamed M, Pavelka K, Poór G, Rubbert-Roth A, Schulze-Koops H, Strangfeld A, Tanaka Y, Smolen J. Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Ann Rheum Dis 2022
Aug 11, 2022Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Aug 11, 2022Ann Rheum Dis 2022
Aletaha Daniel, Kerschbaumer Andreas, Kastrati Kastriot, Dejaco Christian, Dougados Maxime, McInnes Iain B, Sattar Naveed, Stamm Tanja, Takeuchi Tsutomu, Trauner Michael, van der Heijde Désirée, Voshaar Marieke, Winthrop Kevin, Ravelli Angelo, Betteridge Neil, Burmester Gerd-Rüdiger, Bijlsma Johannes Wj, Bykerk Vivian, Caporali Roberto, Choy Ernest H S, Codreanu Catalin, Combe Bernard, Crow Mary K, de Wit Maarten, Emery Paul, Fleischmann Roy, Gabay Cem, Hetland Merete Lund, Hyrich Kimme L, Iagnocco Annamaria, Isaacs John D, Kremer Joel M, Mariette Xavier, Merkel Peter A, Mysler Eduardo F, Nash Peter, Nurmohamed Michael T, Pavelka Karel, Poór Gyula, Rubbert-Roth Andrea, Schulze-Koops Hendrik, Strangfeld Anja, Tanaka Yoshiya, Smolen Josef S
Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Rehberg M, Choy E, Rubbert-Roth A, Castañeda S, Schwarting A, Gottenberg J, Curtis J, Iglesias-Rodriguez M, van Hoogstraten H, Praestgaard A, Giegerich C, MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators. Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data. Rheumatol Ther 2021; 8:1921-1922.
Dec 1, 2021Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Dec 1, 2021Rheumatol Ther 2021; 8:1921-1922
Rehberg Markus, Choy Ernest H S, Rubbert-Roth Andrea, Castañeda Santos, Schwarting Andreas, Gottenberg Jacques-Eric, Curtis Jeffrey R, Iglesias-Rodriguez Melitza, van Hoogstraten Hubert, Praestgaard Amy, Giegerich Clemens, MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators
Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Rehberg M, Choy E, Rubbert-Roth A, Castañeda S, Schwarting A, Gottenberg J, Curtis J, Iglesias-Rodriguez M, van Hoogstraten H, Praestgaard A, Giegerich C, MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators. Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data. Rheumatol Ther 2021; 8:1661-1675.
Sep 14, 2021Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Sep 14, 2021Rheumatol Ther 2021; 8:1661-1675
Rehberg Markus, Choy Ernest H S, Rubbert-Roth Andrea, Castañeda Santos, Schwarting Andreas, Gottenberg Jacques-Eric, Curtis Jeffrey R, Iglesias-Rodriguez Melitza, van Hoogstraten Hubert, Praestgaard Amy, Giegerich Clemens, MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators